Bio-Techne
Bio-Techne Corporation develops, manufactures and sells life science reagents, instruments and services for the research, diagnostic, and bioprocessing markets. The company's brands include R&D Systems, ProteinSimple, and Novus Biologicals. History The company was founded in 1976 by Dr. Roger C. Lucas as Research and Diagnostic Systems, Inc. In 1985, it merged into Techne Corporation and became a public company. In March 2013, Charles (Chuck) Kummeth was named chief executive officer of the company. In July 2013, the company acquired Bionostics for $104 million. In February 2014, the company changed its name to Bio-Techne. In April 2014, the company agreed to acquire Shanghai PrimeGene Bio-Tech Company (PrimeGene). In July 2014, the company acquired Novus Biologicals for $60 million. In August 2014, the company acquired ProteinSimple for $300 million. In November 2014, the company agreed to acquire CyVek for $60 million plus up to an additional $135 million in earn-out payments. In June 2015, the company agreed to acquire Cliniqa Corporation. In March 2016, the company acquired Zephyrus Biosciences. In July 2016, the company acquired Space Import-Export. In August 2016, company acquired Advanced Cell Diagnostics for $250 million plus an additional $75 million in possible milestone payments. In September 2017, the company